{ "items" : [
    { "id" : "http://dbpedia.org/resource/Cimetidine"
      "properties" : {
        "http://www.w3.org/2000/01/rdf-schema#comment" : [ "Cimetidine INN (/sɨˈmɛtɨdiːn/ or /saɪˈmɛtɨdiːn/) is a histamine H2-receptor antagonist that inhibits stomach acid production.  It is largely used in the treatment of heartburn and peptic ulcers.  It has been  marketed by GlaxoSmithKline (which is selling the brand to Prestige Brands) under the trade name Tagamet (sometimes Tagamet HB or Tagamet HB200)." ] ,
        "http://xmlns.com/foaf/0.1/depiction" : [ "http://commons.wikimedia.org/wiki/Special:FilePath/Cimetidine2DACS.svg" ] ,
        "http://dbpedia.org/ontology/atcPrefix" : [ "A02" ] ,
        "http://dbpedia.org/ontology/atcSuffix" : [ "BA01" ] ,
        "http://dbpedia.org/ontology/bioavailability" : [ 60 ] ,
        "http://dbpedia.org/ontology/casNumber" : [ "51481-61-9" ] ,
        "http://dbpedia.org/ontology/chEBI" : [ "3699" ] ,
        "http://dbpedia.org/ontology/drugbank" : [ "DB00501" ] ,
        "http://dbpedia.org/ontology/fdaUniiCode" : [ "80061L1WGD" ] ,
        "http://dbpedia.org/ontology/iupacName" : [ "1-cyano-2-methyl-3-(2-{[4-methyl-1H-imidazol-5-yl)methyl]sulfanyl}ethyl)guanidine" ] ,
        "http://dbpedia.org/ontology/pubchem" : [ "2756" ] ,
        "http://dbpedia.org/ontology/thumbnail" : [ "http://commons.wikimedia.org/wiki/Special:FilePath/Cimetidine2DACS.svg?width=300"] } } }
